tiprankstipranks
pc:regen

Rege Nephro Co Ltd

46-29 Yoshidashimoadachi-cho, Sakyo-ku Med-Pharm Collaboration bldg. Kyoto University Kyoto, Kyoto 606-8501, JP
https://www.regenephro.co.jp/en
Rege Nephro Co., Ltd. is a South Korean company specializing in the development of regenerative treatments for kidney diseases. The company is advancing clinical trials for RN-014, a promising treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD), and preparing for U.S. clinical trials. Additionally, Rege Nephro is completing preclinical trials for RN-032, a cell therapy product targeting Chronic Kidney Disease (CKD).

Leadership & Board

Current Number of Employees15
Current LinkedIn Followers300

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$15M
Total Amount Raised$15M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$15M
Latest Funding Amount$15M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

Rege Nephro Co Ltd had 15 employees as of May 18, 2026. The number of employees increased by 0 (0.00%) week-over-week.
15Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Rege Nephro Co Ltd had 300 followers as of May 18, 2026. The number of followers increased by 0 (0.00%) week-over-week.
300Latest Followers Count
0(0.00%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series B
$15.00M

Related News and Analysis